alcium ion (Ca 2+ ) is a major intracellular messenger with a vital role in many cellular responses. In cardiac myocytes, Ca 2+ not only transmits an electrical signal to the sarcomere thereby triggering a mechanical event, but also induces the expression of genes responsible for hypertrophy or apoptosis. Signaling via Ca 2+ occurs through transient changes in the intracellular Ca 2+ concentration ([Ca 2+ ]i), which is maintained between 10 nmol/L and 10 μmol/L with physiological Ca 2+ transients occurring within this range. The diversity of Ca 2+ -mediated effects is attributable to differences in the amplitude and spatiotemporal pattern of Ca 2+ transients. 1 In cardiac myocytes, intracellular Ca 2+ has 2 origins: the extracellular space and the sarcoplasmic reticulum (SR). The roles of the SR and ryanodine receptors in heart disease have been described by Yano. 2 Here, we focus here on the involvement of Ca 2+ -entry channels in the development of heart disease.
On the basis of sequence similarities, the TRP family can be divided into 7 main subfamilies with the following accepted nomenclature: 5 TRPC (canonical), TRPV (vanilloid), TRPM (from the tumor suppressor melastatin), TRPP (polycystin), TRPML (mucolipin), TRPA (ankyrin), and TRPN (no mechanoreceptor potential C).
TRP membrane proteins consist of 6 transmembrane helices (TM1-6), cytoplasmic N-and C-termini, and a pore region between TM5 and TM6 ( Figure 1 ). All TRP channels have multiple regulatory and protein interaction sites. Protein kinase A and C putative phosphorylation sites have been identified, although the role of phosphorylation in channel function remains to be fully elucidated. Phosphatidylinositide 3-kinase SH2-recognition domains have also been identified in several TRP channels. Functional TRP channels are homotetramers of 1 type of TRP subunit or heterotetramers of different TRP subunit types. Homo-and heteromeric assembly enables TRP proteins to form different cation channels and regulate various cell functions. TRP channels contribute to changes in [Ca 2+ ]i directly by acting as Ca 2+ -entry channels in the plasma membrane or indirectly by changing the membrane potential, thereby increasing the driving force for Ca 2+ entry. All functionally characterized TRP channels are permeable to Ca 2+ with the exception of TRPM4 and TRPM5, which are permeable only to monovalent cations. Most Ca 2+ -permeable TRP channels are poorly selective for Ca 2+ , with a permeability ratio relative to Na + (PCa/PNa) in the range of 0.3 to 10. Two exceptions are TRPV5 and TRPV6, which are highly Ca 2+ -selective channels with a PCa/PNa greater than 100. TRP channels are gated by diverse stimuli that include the binding of intracellular and extracellular messengers, 6 changes in temperature, 7 and chemical 8 or mechanical 9 stress; thus, these channels function as primary sensing molecules in the cell. Some TRP channels appear to be constitutively open ( Table 1) .
In the heart as a whole, the reverse-transcription polymerase chain reaction (RT-PCR) and biochemical studies have demonstrated the expression of several TRP channels (TRPC1, C2-7; TRPV2, -V4; TRPM4, -M5, -M7; and TRPP2/1; see Table 2 ). 10 
TRPC Channels in the Development of Cardiac Hypertrophy
Several pathological conditions (eg, hypertension and valvular heart disease) increase the production of neurohumoral factors and mechanical stresses in the myocardium, which subsequently activate intracellular signal transduction, leading to cardiac hypertrophy. 11, 12 Intracellular Ca 2+ acts to induce the hypertrophic response, although the source of the Ca 2+ responsible for this is still elusive. Research in this area has been hindered by a lack of the molecular identity of the proteins involved. Previous studies have convincingly demonstrated the sufficiency of calcineurin in mediating cardiac hypertrophy and progressive heart failure. 13 Calcineurin dephosphorylates transcription factors of the nuclear factor of the activated T cells (NFAT) family and translocates them into the nucleus, resulting in the activation of hypertrophic response genes. The calcineurin/NFAT pathway was first defined in lymphocytes, where it was demonstrated that NFAT remains in the nucleus only in response to prolonged, low-amplitude Ca 2+ signals and is insensitive to transient, high-amplitude Ca 2+ fluctuations. [14] [15] [16] In cardiac myocytes, Ca 2+ enters through VGCC and subsequently releases more Ca 2+ from the SR, producing a large increase in [Ca 2+ ]i, which is fully reversible over a period of milliseconds. Thus, because VGCC are linked to high-amplitude Ca 2+ transients, these channels would be inadequate for activating calcineurin. The neurohumoral factors endothelin (ET) and angiotensin II (Ang II), known as hypertrophic stimulants, bind G proteincoupled receptors and produce the secondary messengers inositol-1, 4, 5-triphosphate (IP3) and DAG. DAG activates ROC, which mediate sustained Ca 2+ entry, whereas IP3 induces Ca 2+ release from the SR, producing a transient increase in [Ca 2+ ]i. The subsequent depletion of Ca 2+ stores triggers the opening of SOC in the plasma membrane and leads to store-operated Ca 2+ entry (SOCE), which also elicits a sustained increase in [Ca 2+ ]i. A recent study has shown that SOCE contributes to NFAT nuclear translocation and cardiac hypertrophy. 17 TRP channels are the best potential candidates for SOC and ROC.
Recent studies have reported the involvement of TRPC channels in cardiac hypertrophy. Bush et al showed that TRPC3 is upregulated in several animal models of cardiac hypertrophy and that TRPC3 promotes cardiomyocyte hypertrophy. 18 Kuwahara et al stated that TRPC6 is upregulated in mouse hearts in response to activated calcineurin and pressure overload and that the knockdown of TRPC6 reduced hypertrophic signaling induced by phenylephrine and ET-1. 19 TRPC6 transgenic mice exhibited increased NFAT activity and cardiomyopathy. Furthermore, Onohara et al showed that the siRNA-mediated knockdown of TRPC3 or TRPC6 attenuated Ang II-induced NFAT activation and cardiomyocyte hypertrophy. 20 We have shown that in addition to TRPC3 and TRPC6, TRPC1 functions as a SOC in cardiomyocytes and that its upregulation is involved in the development of cardiac hypertrophy. Gene silencing of TRPC1 using siRNA markedly attenuated the hypertrophy response. 21 Although several different TRPC isoforms were examined in these studies, the findings do not preclude a role for other TRPC in mediating hypertrophic responses, because both SOC and ROC are thought to be heteromultimers, consisting of different TRPC subunits. Functional heterogeneity in the hypertrophied myocardium might be partly linked to the diversity of heteromeric assemblages of TRP isoforms. Interestingly, TRPC1 has been identified as a mechanosensitive channel as well as a RAC. 22 The gating promiscuity of TRPC1 might account for the induction of cardiac hypertrophy by various stimuli, such as mechanical stress and neurohumoral factors.
TRPC1, TRPC3, and TRPC6 have conserved NFAT consensus sites in their promoters. 18, 19, 21 Thus, activated NFAT could conceivably stimulate TRPC channel expression through a positive feedback mechanism. As clinically important cardiac hypertrophy arises over the long term, this positive feedback mechanism could feasibly stimulate the development of cardiac hypertrophy (Figure 2) . However, the mechanism for the regulation of TRP expression remains unclear. We have demonstrated that neuron-restrictive silencer factor, which represses the expression of multiple fetal cardiac genes, 23 regulates TRPC1 gene expression in the development of cardiac hypertrophy. 24 Further studies exploring the mechanisms of TRPC channel regulation could lead to the development of novel therapeutic strategies for preventing cardiac hypertrophy.
TRPC Channels and Heart Failure
Altered intracellular Ca 2+ handling contributes to impaired pump function in heart failure. Intracellular Ca 2+ stores and the Ca 2+ -ATPase (SERCA2 isoform) in the SR play prominent roles in contractile activation and relaxation. Increased expression levels of NCX have been detected in conjunction with SERCA downregulation in failing hearts. In addition, an in vitro study using siRNA against SERCA demonstrated that a reduction in SERCA2 expression was associated with the upregulation of TRPC4, TRPC5, and NCX, suggesting that Ca 2+ entry through the plasma membrane might compensate for a deficiency in intracellular Ca 2+ stores. 25 Indeed, the induction of TRPC5 or TRPC6 expression is seen in the failing human heart. 18, 19 The importance of this compensatory mechanism might be related to its general involvement in Ca 2+ signaling mechanisms for not only excitation-contraction coupling but also cardiac remodeling.
As time passes, compensated cardiac hypertrophy progresses to heart failure, in which apoptotic cells are more abundant in contrast to the non-failing heart. Therefore, apoptosis might be involved in the development of heart failure after cardiac hypertrophy. As described above, the contribution of TRPC to cardiac hypertrophy has been suggested; however, there is no direct evidence linking the upregulation of TRPC to the development of heart failure after hypertrophy.
Myocardial apoptosis is a critical process in heart failure, making the inhibition of apoptosis a promising therapeutic option. The apoptotic process is evoked by various stimuli, including oxidative stress, pro-inflammatory cytokines, catecholamines, and Ang II. 26 An increase in cytosolic Ca 2+ might be a key initiator of the intracellular signaling of apoptosis (eg, activation of Ca 2+ -dependent endogenous endonuclease). At present, the involvement of 3 TRP channels in myocardial apoptosis has been reported in an animal model. First, the activations of the TRPM2 channel and poly(ADP-ribose) polymerase are involved in oxidative stress-induced cardiomyocyte death. 27 The apoptotic component is caused by the activation of clotrimazole-sensitive, NAD + /ADP ribose/poly(ADP-ribose) polymerase-dependent TRPM2 channels, which induces mitochondrial Na + and Ca 2+ overload, resulting in mitochondrial membrane disruption, cytochrome c release, and caspase 3-dependent chromatin condensation/fragmentation. Second, Satoh et al showed that TRPC7 might be a vital initiator linking the activation of angiotensin type 1 receptors to myocardial apoptosis, thus contributing to heart failure. 28 Third, a study on mice that overexpressed TRPC3 showed that SOCE, mediated via TRPC3, might contribute to cardiomyocyte apoptosis following ischemia-reperfusion. 29 Although these findings point to possible therapeutic strategies for modulating cardiac apoptosis, further investigation is required to clarify the complex and intricate balance between cardiac Table 1. apoptosis and heart failure. Growing evidence implicates cardiac fibrosis in the outcome of heart failure and incidence of atrial fibrillation. 30 Cardiac fibroblasts are responsible for the synthesis and secretion of the extracellular matrix proteins collagen (types I and II) and matrix metalloproteinases, and serve as mediators of inflammatory and fibrotic myocardial remodeling in injured hearts. [30] [31] [32] Although natriuretic peptides including C-type natriuretic peptide, is known to have antifibrotic effects on cardiac fibroblasts, 33 little is known about the underlying ion mechanisms. Recently, Rose et al reported that cardiac fibroblasts express NSCC that are potently activated by natriuretic peptide C, in which TRPC2, TRPC3, and TRPC5 mRNA were expressed. 34 Natriuretic peptide C -activated NSCC was antagonized by TRP channel blockers Gd 3+ , SKF 96365 and 2-aminoethoxydiphenyl borate (2-APB), and were mimicked by intracellular application of 1-oleyl-2-acetyl-sn-glycerol (OAG), independently of protein kinase C activity. 35 These results indicate the possible involvement of TRP channels in antifibrotic effects of natriuretic peptide C. In another study, ET-1-induced myofibroblast formation was suppressed by overexpression of TRPC6, whereas it was enhanced by small interfering RNAs against TRPC6. Upregulation of TRPC6 inhibits ET-1-induced cardiac myofibroblast formation and collagen synthesis through the activation of NFAT. 36 These studies point the way to future challenges in cardiac fibroblast biology and pharmacotherapy.
TRP Channels and Dilated Cardiomyopathy in Muscular Dystrophy
Muscular dystrophies are disorders of progressive skeletal muscle degeneration. The most common X-linked recessive disease is Duchenne muscular dystrophy (DMD), which arises from defects in the dystrophin gene. Some DMD patients develop a dilated cardiomyopathy, which leads to heart failure. It is not known why the absence of the dystrophin protein induces cardiomyocyte degeneration leading to heart failure, but changes in Ca 2+ handling are involved in the pathogenic process. One study showed that a lack of dystrophin resulted in increased activity of SAC in skeletal muscle. 37 The resulting increase in resting [Ca 2+ ]i might activate proteases and has been implicated in the pathogenesis of muscle damage in DMD. Conversely, blocking SAC prevented the rise in [Ca 2+ ]i following stretch in mdx muscle, a mouse model of DMD, and also prevented some of the subsequent muscle damage. 38 Therefore, SAC might play a Proposed mechanism for the development of cardiac hypertrophy via the TRPC/calcineurin/ nuclear factor of the activated T cells (NFAT) pathway. Hypertrophic stimulation by neurohormonal factors produces diacylglycerol (DAG) and IP3. DAG directly activates receptor-operated Ca 2+ channels (ROC). IP3 acts through the IP3 receptor to release Ca 2+ from the sarcoplasmic/endoplasmic reticulum, resulting in Ca 2+ store depletion, which subsequently opens store-operated Ca 2+ channels (SOC). Mechanical stress activates stretch-activated cation channels (SAC). These Ca 2+ -entry channels (ROC, SOC, and SAC), which consist mainly of TRPC channel homo-/heteromultimers in various combinations, induce a prolonged, low-amplitude rise in Ca 2+ . This sustained Ca 2+ entry dominantly activates the calcineurin/NFAT pathway. The brain natriuretic peptide gene is one of the downstream targets of the TRPC/calcineurin/NFAT pathway. NFAT increases TRPC gene transcription, which enhances TRPC protein expression. The increase in TRPC channels further activates the calcineurin/NFAT pathway. This feed-forward mechanism produces long-term hypertrophic changes in cardiac myocytes.
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role in the pathogenesis of heart failure associated with DMD. A critical issue is the molecular identification of SAC, and some TRP (eg, TRPC1, TRPC6, and TRPV2) are likely candidate proteins for SAC in cardiac myocytes. It was recently shown that the expression of TRPC1 protein was increased in older mdx mice. 39 Gervásio et al. reported that hydrogen peroxide, a reactive oxygen species (ROS), increased Src activity and activates TRPC1 colocalized with caveolin-3 at the plasma membrane in myoblasts. Given that ROS production is increased in DMD, a ROS-Src-TRPC1/ caveolin-3 pathway might be involved in its pathogenesis. 40 Isolated myocytes from old mdx animals exhibited an elevated level of resting [Ca]i, which was blocked by the application of GsMTX-4, known as a TRPC6 blocker. 41 Moreover, the increased expression of TRPV2 might cause cardiac muscle degeneration in dystrophic cardiomyopathy. 42 These findings suggest that SAC -and in particular, TRPC1, TRPC6, and TRPV2 -contribute to the pathogenesis of cardiomyopathy associated with DMD.
TRPP2 Channels and Cardiac Defects
Mutations in either the PKD-1 or PKD-2 gene lead to autosomal dominant polycystic kidney disease, a common inherited disorder characterized by progressive development of fluid-filled cysts in the kidneys and a number of extrarenal manifestations, including hepatic and pancreatic cysts, cardiac valvular abnormalities, hypertension, and cerebral and aortic aneurysms. The respective gene products of PKD1 and PKD2 are called TRPP1 and TRPP2, or polycystin 1 and polycystin 2. TRPP1 and TRPP2 are thought to function either together as part of a multiprotein receptor/ion-channel complex or independently. Cystic tissue is assumed to lack functional TRPP1/TRPP2, which acts as a negative regulator of cell growth. TRPP2-deficient mice have structural defects in cardiac septation. 43 Given that TRPP2-like large conductance cation channels have been found in the heart 44 and that the expression pattern of TRPP2 during heart development is relatively stable, 45 TRPP2 channels might be involved in the normal development of the interventricular and interatrial septa. The inactivation of the gene encoding tolloid-like 1, a bone morphogenetic protein-1-related metalloprotease, produces a cardiac-restricted phenotype 46 that resembles the phenotype of TRPP2 -/-mice. Tolloid-like 1 might affect heart morphogenesis through a pathway that involves transforming growth factor-like molecules and matrix deposition, which are factors that could be involved in a potential 'TRPP2 pathway' in the heart. However, a detailed mechanism remains elusive. Further studies are required to clarify the physiological importance of TRPP2 and to determine the role of TRPP2 in cardiac development. It is interesting that the cardiac phenotypes found in TRPP2 -/-mice are not seen in TRPP1 del34/del34 mice. Moreover, a TRPP1-independent function of TRPP2 in left-right asymmetry development during embryogenesis has been reported. 47 It is possible that TRPP2 activity in the developing heart involves interactions with cardiac-specific partners distinct from TRPP1.
Previous report showed TRPP3 expression in the heart; however, TRPP3 is thought to be expressed in the epicardium and ventricular blood vessels to a greater degree that in heart muscle, 48 and no phenotype in the cardiovascular system has been observed in TRPP3 mutated mice. 49 Therefore, further studies are required to clarify the physiological importance of TRPP3, and to determine the role of TRPP3 in cardiac development. 50 
Involvement of TRP Channels in Pacemaking in the Sinoatrial Node
Although growing evidence indicates that diastolic depolarization can be generated by an inward NCX current related to Ca 2+ -induced Ca 2+ release from the SR, whether SR Ca 2+ release is essential for cardiac pacemaker function is debatable. 51 Ju and colleagues reported on the SOC current, which might be involved in pacemaking. 52 They found that a SOC blocker, SK&F-96356, slowed the firing rate and that pacemaker firing was further slowed when the SR Ca 2+ stores were depleted with cyclopiazonic acid. In addition, they provided RT-PCR evidence of transcripts for 6 of the 7 TRPC channels (the exception was TRPC5) in the sinoatrial node. Because TRPC proteins are a pivotal component for SOC (1 exception to this is TRPC6), these studies raise the possibility that TRPC isoforms are responsible for SOC activity and contribute to pacemaker firing. More direct evidence on this point is needed.
The expression of TRPM4 was also demonstrated in mouse sinoatrial node cells. 53 The functional property of a non-selective cation channel (NSCC) in mouse sinoatrial node cells shows the hallmarks of the TRPM4 channel. It is activated by a rise in [Ca 2+ ]i and is voltage dependent, with a conductance of 20.9±0.5 pS. It is equally permeable to Na + and K + but does not conduct Ca 2+ . These data suggest a Ca 2+ -activated NSCC in mouse sinoatrial node cells corresponding to TRPM4. Although it is not known whether the peak Ca 2+ level achieved is sufficiently high to activate the TRPM4 channel, TRPM4 might be a new therapeutic target for controlling heart rhythm.
TRP Channels Participate in Arrhythmogenesis
Mechanical stretch is a cause of cardiac arrhythmia. The activation of stretch-activated channels contributes to depolarization of the membrane potential, shortened refractoriness, slowed conduction, and increased spatial dispersion. 54 Several types of SAC have been described in the cardiac cell: potassium-selective channels, 55 chloride-selective anion channels, 56, 57 and non-selective cation channels. 58 Bode et al showed that atrial fibrillation potentiated by dilatation in rabbit heart can be inhibited by blocking SAC with GsMTx4, a peptide isolated from tarantula venom and the first specific reagent for non-selective cation SAC. 59 However, the molecular composition of SAC in cardiomyocytes is unclear. Mechanical deformation of ventricular myocytes modulates TRPC6 activity, which is inhibited by GsMTx4. 60, 61 Therefore, manipulation of TRPC6 function might be a therapeutic strategy for preventing mechanical stretch-induced arrhythmia.
Cardiac arrhythmias, which occur under a wide variety of conditions when [Ca 2+ ]i is elevated, have been attributed to the activation of a transient inward current. This current is the result of various [Ca 2+ ]i-sensitive currents, including a Ca 2+ -activated nonselective, cationic current. Since the first single-channel measurements in cardiac cells revealing a Ca 2+ -activated NSCC were reported, 62,63 considerable effort has been undertaken to identify molecular candidates for this channel. One recent study has indicated that this is likely a TRPM4 channel. 64 In the heart, TRPM4 seems to be expressed to a greater degree in the atrial myocardium than in the ventricular myocardium. 65 Functional characterization of a Ca 2+ -activated NSCC in human atrial cardiomyocytes using the patch-clamp technique has shown that the channel is equally permeable to Na + and K + but is not permeable to Ca 2+ and that the properties of the 25-pS NSCCCa channel match very closely those of TRPM4. 66 These findings suggest that TRPM4 is a serious candidate for the protein supporting the delayed after-depolarization observed under conditions of Ca 2+ overload and might cause irregular electrical activity. A follow-up study by the same group demonstrated increased TRPM4 expression in cardiac hypertrophy, using freshly isolated ventricular myocytes from spontaneously hypertensive rats. 67 The expression level of TRPM4 mRNA is much higher in spontaneously hypertensive rats than in Wistar-Kyoto rats, and the expressed TRPM4 is functional, as TRPM4 current is recordable in spontaneously hypertensive, but not in Wistar-Kyoto, rat cardiac myocytes. Therefore, TRPM4 might participate in some aspects of cardiac arrhythmias associated with Ca 2+ overload or cardiac hypertrophy.
TRPV1 Channel in Cardiac Sensory Neurons
Chest pain is a hallmark of myocardial ischemia, but its underlying signaling mechanisms remain poorly understood. The cardiac sensory afferents and their cell bodies in the dorsal root ganglion are generally considered the essential pathways for the transmission of cardiac nociception to the dorsal horn of the upper thoracic spinal cord. Increased production of bradykinin during myocardial ischemia might contribute to the excitation of cardiac nociceptors in cardiac sensory neurons responsible for chest pain. Recently, Pan et al provided new evidence that iodoresiniferatoxin, a selective antagonist of TRPV1, attenuates both bradykinin-and ischemia-induced firing of cardiac spinal afferent nerves. 68 Therefore, it is likely that ischemic stimulation of cardiac spinal afferent nerves is mediated through TRPV1. TRPV1 located on the cardiac sensory nerve might function as a molecular sensor to detect tissue ischemia and activate cardiac nociceptors. Blocking TRPV1 on cardiac sensory neurons might be an alternative intervention for the treatment of refractory ischemic chest pain that cannot be relieved using conventional therapies.
It has been postulated that in addition to TRPV1's role as a detector of pain-producing stimuli, its activation causes the release of substance P, CGRP, and other neurokinins from sensory nerve terminals, protecting the heart from ischemic injury. Recent evidence implicates TRPV1 located on sensory C-fibers in cardioprotection. Wang et al. found that the postischemic recovery of various hemodynamic parameters was impaired in TRPV1 -/-mice compared with wild-type mice. 69 Sexton et al. showed that myocardial ischemia generates 12-lipoxygenase-derived eicosanoids, which protect against myocardial ischemia/reperfusion injury via the activation of neuronal TRPV1 and the subsequent release of substance P and calcitonin gene-related peptide. 70 Furthermore, Zhong and Wang showed that N-oleoyldopamine, a novel endogenous capsaicin-like lipid, protects the heart against ischemiareperfusion injury via the activation of TRPV1. 71 This result might have important clinical implications, suggesting that the blocking of TRPV1 results in a greater vulnerability to ischemia/reperfusion injury. Further studies are required to elucidate whether the blocking of neuronal TRPV1 has beneficial effects on myocardial ischemia.
Conclusions
TRP channels, which include SOC, ROC, SAC, and LGC Ca 2+ -entry channels, are expressed in nearly all cardiovascular tissues. The functional significance of TRP channels is likely connected to the integration of multiple physical and chemical gating stimuli to induce Ca 2+ entry. Therefore, the involvement of TRP channels in cardiovascular disease is of specific interest, as it offers the opportunity to modulate Ca 2+ -dependent signaling processes in the cardiovascular system. Although the limited number of compounds that specifically block or activate respective TRP channels hinders the analysis of TRP channel function, studies linking TRP channel function to heart disease will undoubtedly become an important priority in medical science. The polymodal function of TRP channels makes them especially attractive targets for future research on therapeutic strategies for treating cardiovascular disease.
